News Living Cell Technologies awarded $100,000 grant by Cure Kids New Zealand Living Cell Technologies (ASX:LCT) today announced Cure Kids New Zealand had awarded the cell therapy company a NZ$100,000 grant to pursue its program of liver cell transplantation treatment of the inherited bleeding disorder, haemophilia. Related Document |